An interventional study of continuous theta burst stimulation in Chronic Tinnitus, sponsored by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. Recruiting at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-12-05.
Sponsored by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 32 studies in Tinnitus with a site in China — 18 open to participants now, 18 under way, none of them phase 3. Tinnitus · China.
Among the 32 studies in Tinnitus with a site in China, this one is the 16th largest by planned enrollment of the 27 interventional ones that give a count, is one of 2 that started in 2025, is one of 27 with no phase, reaches primary completion later than 14 of the 17 other live ones, and was the 25th registered.
446 studies on the registry are indexed under Tinnitus; 98 are open to participants now.
Browse Tinnitus studies →18 of the 32 studies in Tinnitus with a site in China are open now. Recruiting first, the newest first:
The First Affiliated Hospital with Nanjing Medical University · Sites in China
Ages 18+
Eye & ENT Hospital of Fudan University · Sites in China
Ages 18–80
The Third Affiliated hospital of Zhejiang Chinese Medical University · Sites in China
Ages 20–55 · Healthy volunteers
The Third Affiliated hospital of Zhejiang Chinese Medical University · Sites in China
Ages 18–60
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Sites in China
Ages 18–60
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 49 Tinnitus studies recruiting now, 21 (43%) set no upper age limit and 18 (37%) stop at 75 or younger; 4 take children under 18; 10 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
32 studies; the count open now beside each. This study's row is marked.
First in 2016; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 116 is above the median of 60 across 370 interventional studies indexed under Tinnitus.
Median enrollment 120 across the 27 interventional studies, 150 across the 5 observational. Of the 9 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 32 has an industry lead sponsor. The 10 most frequent:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University is the lead sponsor of 485 studies on the registry; 279 are open to participants now.
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University has 8 studies filed under Tinnitus — fewer than ten, so there is no comparison to draw.
5 of the studies in Tinnitus with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07700069Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityAcupuncture Versus Sham Acupuncture for Tinnitus | 2026-12-31 |
| NCT07558837Eye & ENT Hospital of Fudan UniversityFudan Tinnitus Doctor for Tinnitus Management | 2027-05-30 |
| NCT05453019Chinese PLA General HospitalEffects of CI on Tinnitus and Its Symptoms | 2027-07-01 |
| NCT07185061The First Affiliated Hospital with Nanjing Medical UniversityInterventional Treatment of Chronic Tinnitus With Acoustic Stimulation | 2027-07-01 |
| NCT07515482Dan BingManual Acupuncture for Acute Primary Tinnitus | 2027-10-30 |
Add all 5 to your calendar (.ics) → With an account.
Among the 32 studies in Tinnitus with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to evaluate the efficacy and safety of personalized-target transcranial magnetic stimulation (TMS) in the treatment of chronic subjective tinnitus. The study aims to determine whether stimulation at individualized auditory cortex targets, identified by resting-state functional MRI, provides greater therapeutic benefit compared with conventional TMS targets.
A total of 116 patients with chronic tinnitus will be recruited and randomly assigned to receive either personalized-target TMS or traditional-target TMS for five consecutive days.
The main questions this study aims to answer are:
Does personalized-target TMS improve tinnitus-related symptoms more effectively than traditional-target TMS?
Is personalized-target TMS a safe and tolerable intervention for patients with chronic tinnitus?
Researchers will compare the changes in tinnitus-related clinical rating scales between the two groups, including the Tinnitus Handicap Inventory (THI), Visual Analog Scale (VAS), Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), and Pittsburgh Sleep Quality Index (PSQI).
Participants will:
Receive continuous theta burst stimulation (cTBS) targeting the left auditory cortex region showing the strongest functional connectivity with the parahippocampal gyrus, identified through resting-state fMRI.
Undergo three cTBS sessions per day (600 pulses per session, 1,800 pulses total daily) for five days.
Complete follow-up assessments at 1 month and 3 months after treatment to evaluate the durability of clinical effects.
This study will also assess treatment adherence, safety outcomes, and potential predictors of therapeutic response to personalized-target TMS.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
1.Patients with tinnitus as the main complaint: Patients perceive subjective sounds in the ears or deep within the skull in the absence of internal or external acoustic stimulation.
2.Patients with chronic tinnitus who meet the conditions including tinnitus duration of more than 6 months, THI (tinnitus handicap inventory) score ≥ 38, and no response to conventional drug treatment.
3.Outpatients of Sun Yat-sen University Sun Yat-sen Memorial Hospital who can receive continuous 5-day cTBS treatment.
4.Tinnitus frequency ranges from 125 Hz to 8000 Hz. 5.Aged 18-70 years.
Exclusion Criteria:
1.Patients with tinnitus associated with the following conditions: conductive hearing loss, a history of middle ear surgery, pulsatile tinnitus caused by vascular malformations, or Meniere's disease.
2.A history of any of the following: head trauma, central nervous system diseases, psychiatric disorders, or substance abuse.
3.Pregnancy.
Participants receive continuous theta burst stimulation (cTBS) targeting the individualized auditory cortex region showing the strongest functional connectivity with the left parahippocampal gyrus, as identified by resting-state fMRI. Each participant receives 600 pulses per session, 3 sessions per day (total 1,800 pulses daily) for 5 consecutive days.
Device: continuous theta burst stimulation
Participants receive continuous theta burst stimulation (cTBS) targeting the left auditory cortex at EEG 10-20 system site CP5, as used in prior tinnitus studies. Stimulation parameters are identical to the experimental group (600 pulses per session, 3 sessions per day, for 5 consecutive days).
Device: continuous theta burst stimulation
This study evaluates personalized-target and conventional-target transcranial magnetic stimulation (TMS) for the treatment of chronic subjective tinnitus. Participants will receive continuous theta burst stimulation (cTBS) applied to the left auditory cortex. For the personalized-target arm, stimulation sites are individualized based on resting-state fMRI, targeting the region of strongest functional connectivity with the parahippocampal gyrus. For the conventional-target arm, stimulation is delivered at the CP5 site. Each session consists of 600 pulses, delivered in three sessions per day (1,800 pulses daily) for five consecutive days.
the effective rate of chronic tinnitus relief in the two groups of patients before treatment and 5 days after treatment
It is defined as follows: Effective rate = \[(Number of patients in each group who completed the 5-day treatment and had a Tinnitus Handicap Inventory (THI) score decrease of ≥ 7 points from the baseline) / (Total number of patients in each group who completed the 5-day treatment)\] × 100%. The assessment time points for this outcome are before treatment (baseline) and 5 days after treatment.
Time frame: From enrollment to the end of treatment at 5 days
Tinnitus Loudness
Change in tinnitus loudness, assessed using the Visual Analog Scale (VAS), which ranges from 0 (no tinnitus) to 10 (worst tinnitus imaginable).
Time frame: Baseline, post-treatment (day 5), 1-month follow-up, 3-month follow-up
Anxiety Symptoms
Change in anxiety symptoms, assessed using the Beck Anxiety Inventory (BAI), a self-reported questionnaire measuring severity of anxiety.
Time frame: Baseline, post-treatment (day 5), 1-month follow-up, 3-month follow-up
Depressive Symptoms
Change in depressive symptoms, assessed using the Beck Depression Inventory (BDI), a self-reported scale evaluating severity of depression.
Time frame: Baseline, post-treatment (day 5), 1-month follow-up, 3-month follow-up
Sleep Quality
Change in sleep quality, assessed using the Pittsburgh Sleep Quality Index (PSQI), which evaluates sleep quality and disturbances over a 1-month period.
Time frame: Baseline, post-treatment (day 5), 1-month follow-up, 3-month follow-up
Long-term Efficacy of Tinnitus Relief
Effective rate = \[(Number of patients in each group who completed the 5-day treatment and had a Tinnitus Handicap Inventory (THI) score decrease of ≥ 7 points from the baseline) / (Total number of patients in each group who completed the 5-day treatment)\] × 100%. The assessment time points for this outcome are before treatment (baseline) and 1 month, 3 month after treatment.
Time frame: 1-month follow-up, 3-month follow-up
EEG Changes
Changes in electroencephalography (EEG) measures associated with tinnitus and cortical activity, assessed before treatment, after 5 days of intervention, and at 1-month and 3-month follow-ups.
Time frame: Baseline (pre-treatment), post-treatment (day 5), 1-month follow-up, 3-month follow-up
MRI Changes
Changes in brain structure and functional connectivity assessed using magnetic resonance imaging (MRI), including the auditory cortex and related networks. MRI is performed at baseline (pre-treatment) and at 1-month follow-up to evaluate early post-treatment neural changes.
Time frame: Baseline (pre-treatment), 1-month follow-up
Plan to share: No — Individual participant data (IPD) from this study will not be shared due to privacy concerns and ethical restrictions related to patient confidentiality.
No publications or documents are linked to this record.
Started Aug 2025 (actual). Primary completion is estimated for Jan 2030, 53 months after the start.
Of 134 non-industry interventional studies with no phase under Tinnitus, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 38. This study's planned 53 months is above that.
Counting every sponsor, half of 153 studies reached it within 17 months; a quarter within 10 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University →